617
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Coencapsulation of Oxygen Carriers and Glucose Oxidase in Polyelectrolyte Complex Capsules for the Enhancement of D-Gluconic Acid and δ-Gluconolactone Production

, , , , &
Pages 90-98 | Published online: 12 Mar 2010

Figures & data

Figure 1. Chemical equation of glucose oxidation catalysed by glucose oxidase (GOD) and catalase (CAT), compiled according to [Citation2].

Figure 1. Chemical equation of glucose oxidation catalysed by glucose oxidase (GOD) and catalase (CAT), compiled according to [Citation2].

Table 1. Viscosity of the PA solutions and statistical analysis of the size and membrane thickness of GOD-SA-CS/PMCG capsules with coencapsulated oxygen carriers: 4% (w/w) of poly(dimethylsiloxane) (PDMS), 10% (w/w) of n-dodecane (DOD) and 10% of perfluorodecaline (PFD), respectively

Figure 2. Representative images of GOD-SA-CS/PMCG microcapsules: a) reference sample without oxygen carriers; b) capsules with an emulsion of PDMS 4% (w/w) and PFD 10% (w/w); c) capsules with PDMS 4% (w/w); d) capsules with an emulsion of PDMS 4% (w/w) and DOD 10% (w/w). Digitized images were taken either by an optical microscope (a, c) or a stereomicroscope (b, d) equipped with a digital camera and interfaced to a PC.

Figure 2. Representative images of GOD-SA-CS/PMCG microcapsules: a) reference sample without oxygen carriers; b) capsules with an emulsion of PDMS 4% (w/w) and PFD 10% (w/w); c) capsules with PDMS 4% (w/w); d) capsules with an emulsion of PDMS 4% (w/w) and DOD 10% (w/w). Digitized images were taken either by an optical microscope (a, c) or a stereomicroscope (b, d) equipped with a digital camera and interfaced to a PC.

Figure 3. Relative enzyme activities for GOD-SA-CS/PMCG capsules using different oxygen feeding conditions, including air (•) and pure oxygen (○), at different glucose concentrations. Oxygen concentrations in reaction mixtures, measured by an oximeter, were 0.25 mM using air and 0.625 mM using pure oxygen. GOD activities were measured spectrophotometrically. 100% activity = 21.1±1.1 U·g−1.

Figure 3. Relative enzyme activities for GOD-SA-CS/PMCG capsules using different oxygen feeding conditions, including air (•) and pure oxygen (○), at different glucose concentrations. Oxygen concentrations in reaction mixtures, measured by an oximeter, were 0.25 mM using air and 0.625 mM using pure oxygen. GOD activities were measured spectrophotometrically. 100% activity = 21.1±1.1 U·g−1.

Table 2. Comparison of enzyme activity (A) and space-time yield (STY) of the product (mixture of D-gluconic acid and δ-gluconolactone) for GOD-SA-CS/PMCG capsules with the following concentration of coencapsulated oxygen carriers: 4% (w/w) of poly(dimethylsiloxane) (PDMS), 10% (w/w) of n-dodecane (DOD) and 10% (w/w) of perfluorodecaline (PFD), respectively; oxygen concentration was kept at 0.625 mM

Figure 4. Effect of coencapsulated oxygen carriers within the GOD-SA-CS/PMCG capsules expressed as the time evolution of the product (D-gluconic acid – δ-gluconolactone mixture) concentration during glucose oxidation. The oxygen carrier concentrations in PA solution were PDMS 4% (w/w), PFD 10% (w/w), DOD 10% (w/w). GOD-SA-CS/PMCG capsules formed in the absence of oxygen carriers were used as the reference. Product concentrations were determined by HPLC. Oxygen concentration was 0.625 mM.

Figure 4. Effect of coencapsulated oxygen carriers within the GOD-SA-CS/PMCG capsules expressed as the time evolution of the product (D-gluconic acid – δ-gluconolactone mixture) concentration during glucose oxidation. The oxygen carrier concentrations in PA solution were PDMS 4% (w/w), PFD 10% (w/w), DOD 10% (w/w). GOD-SA-CS/PMCG capsules formed in the absence of oxygen carriers were used as the reference. Product concentrations were determined by HPLC. Oxygen concentration was 0.625 mM.

Figure 5. Effect of coencapsulated oxygen carriers within the GOD-SA-CS/PMCG capsules expressed as the time evolution of the glucose concentration monitored on-line by flow microcalorimetry (FC) and sample analysis by HPLC. Depicted concentrations represent average values from measurements by FC and HPLC. The oxygen carrier concentrations in PA solution were PDMS 4% (w/w), PFD 10% (w/w), DOD 10% (w/w). GOD-SA-CS/PMCG capsules formed in the absence of oxygen carriers were used as reference. Oxygen concentration was 0.625 mM.

Figure 5. Effect of coencapsulated oxygen carriers within the GOD-SA-CS/PMCG capsules expressed as the time evolution of the glucose concentration monitored on-line by flow microcalorimetry (FC) and sample analysis by HPLC. Depicted concentrations represent average values from measurements by FC and HPLC. The oxygen carrier concentrations in PA solution were PDMS 4% (w/w), PFD 10% (w/w), DOD 10% (w/w). GOD-SA-CS/PMCG capsules formed in the absence of oxygen carriers were used as reference. Oxygen concentration was 0.625 mM.

Figure 6. Dependence of enzyme activity on concentration of MnO2 coencapsulated within the GOD-SA-CS/PMCG capsules. GOD activities were determined spectrophotometrically. Oxygen concentration was 0.625 mM.

Figure 6. Dependence of enzyme activity on concentration of MnO2 coencapsulated within the GOD-SA-CS/PMCG capsules. GOD activities were determined spectrophotometrically. Oxygen concentration was 0.625 mM.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.